Stock Performance and Corporate Update – Chemometec A/S (CHEMM.CO)
Trading Overview (24‑hour period ending 08:11 PM CET, Thursday 22 October 2026)
- Closing price: DKK 595.00
- Percentage change: +3.56 %
- Shares outstanding: 17.2 million
- Market capitalization: DKK 10.2 bn
- Volume traded: DKK 30.8 mn worth of shares
- Year‑to‑date change: +15.83 % since the end of the previous month
- 200‑day simple moving average: DKK 444.66
- 52‑week high: DKK 804 (recorded 30 October 2025)
- 52‑week low: DKK 235.2 (recorded 24 March 2026)
Recent Corporate Announcement On 21 October 2026, Chemometec A/S disclosed a change in its major shareholder structure. BlackRock, Inc. reported that it reduced the voting rights attached directly to its shares to 14.97 %, falling below the 15 % threshold. Concurrently, BlackRock increased its voting rights through financial instruments to 0.11 %, maintaining an overall voting position of approximately 15.08 %. Management confirmed that the total voting rights held by the entity remained unchanged. The announcement complied with Danish capital‑market disclosure regulations and was communicated via official press releases.
Business Focus Chemometec A/S, established in 1997, designs and manufactures instruments for cell counting and related measurements. Products include the NucleoCounter series, Xcyto quantitative cell imager, NucleoView software, consumables, and accessories. Applications span cell therapy, stem cell research, oncology, bioprocessing, toxicology, and agricultural sectors.
Comparative Performance of Selected Danish Shares (Last 24 Hours)
| Symbol | Current Price (DKK) | % Change | Market Cap (DKK bn) | P/E Ratio |
|---|---|---|---|---|
| JDAN.CO | 199.00 | +1.02 % | 10.9 | 10.92 |
| DFDS.CO | 155.00 | +2.30 % | 8.6 | – |
| SJF.CO | 465.00 | +0.96 % | 7.7 | 13.75 |
| EMBLA.CO | 26.20 | 0 % | 11.1 | 17.77 |
| STG.CO | 77.70 | –0.38 % | 6.2 | 9.67 |
DFDS has a modest net short exposure (~0.4 %) and shows stable short‑interest trends. Scandinavian Tobacco maintains a small short‑net position, with no significant volatility observed.
Summary Chemometec A/S experienced a notable intraday rise, contributing to a positive month‑to‑date performance. The shareholder adjustment by BlackRock maintains the company’s voting structure within regulatory thresholds. The broader Danish equity snapshot indicates varied short‑position activity, with most listed firms showing stable or low exposure.
